Ophthalmology

Green light to dexamethasone for the treatment of common eye condition in draft guidance

In final draft guidance published today (6 June) NICE has recommended dexamethasone (Ozurdex, Allergan) intravitreal implant, for the treatment of macular oedema following central retinal vein occlusion (CRVO). It is also recommended following branch retinal vein occlusion (BRVO) when treatment with laser photocoagulation has not been beneficial, or treatment with laser photocoagulation is not considered suitable because of the extent of macular haemorrhage.
Read more

 http://www.nice.org.uk/newsroom/pressreleases/GreenLightToDe...

National Institute for Health and Clinical Excellence